BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,008,749 | -1.2% | 53,226 | +19.3% | 0.01% | 0.0% |
| Q2 2023 | $2,032,295 | +32.7% | 44,607 | +18.2% | 0.01% | +20.0% |
| Q1 2023 | $1,530,978 | -40.5% | 37,746 | -25.2% | 0.01% | -41.2% |
| Q4 2022 | $2,571,284 | -19.5% | 50,447 | -14.9% | 0.02% | -22.7% |
| Q3 2022 | $3,193,000 | +28.3% | 59,276 | +53.0% | 0.02% | +37.5% |
| Q2 2022 | $2,488,000 | -14.8% | 38,742 | +2.9% | 0.02% | 0.0% |
| Q1 2022 | $2,919,000 | +160.2% | 37,650 | +188.1% | 0.02% | +166.7% |
| Q4 2021 | $1,122,000 | -24.5% | 13,069 | -29.2% | 0.01% | -25.0% |
| Q3 2021 | $1,486,000 | +5.9% | 18,470 | +5.9% | 0.01% | 0.0% |
| Q2 2021 | $1,403,000 | -65.1% | 17,433 | -63.5% | 0.01% | -65.2% |
| Q1 2021 | $4,025,000 | +96.2% | 47,725 | +86.7% | 0.02% | +91.7% |
| Q4 2020 | $2,051,000 | -48.4% | 25,562 | -48.2% | 0.01% | -52.0% |
| Q3 2020 | $3,971,000 | -5.6% | 49,380 | +1.0% | 0.02% | -7.4% |
| Q2 2020 | $4,208,000 | -9.6% | 48,873 | -14.7% | 0.03% | -18.2% |
| Q1 2020 | $4,654,000 | -10.9% | 57,323 | -8.2% | 0.03% | +37.5% |
| Q4 2019 | $5,223,000 | -4.8% | 62,467 | -0.4% | 0.02% | -4.0% |
| Q3 2019 | $5,488,000 | +2.6% | 62,744 | -4.0% | 0.02% | +4.2% |
| Q2 2019 | $5,351,000 | +0.8% | 65,338 | +0.1% | 0.02% | 0.0% |
| Q1 2019 | $5,310,000 | -3.2% | 65,302 | -21.6% | 0.02% | -7.7% |
| Q4 2018 | $5,485,000 | +14.6% | 83,337 | +34.3% | 0.03% | +44.4% |
| Q3 2018 | $4,785,000 | -77.2% | 62,070 | -78.1% | 0.02% | -78.3% |
| Q2 2018 | $20,970,000 | -56.2% | 283,993 | -61.4% | 0.08% | -56.1% |
| Q1 2018 | $47,859,000 | -15.9% | 735,838 | -16.4% | 0.19% | -11.7% |
| Q4 2017 | $56,922,000 | -20.9% | 880,601 | -23.2% | 0.21% | -24.9% |
| Q3 2017 | $71,988,000 | -5.4% | 1,147,215 | -8.8% | 0.28% | -6.9% |
| Q2 2017 | $76,124,000 | +38.7% | 1,257,411 | +18.8% | 0.31% | +33.6% |
| Q1 2017 | $54,876,000 | -33.0% | 1,058,157 | -42.8% | 0.23% | -38.9% |
| Q4 2016 | $81,963,000 | +39.0% | 1,848,506 | +49.2% | 0.38% | +33.5% |
| Q3 2016 | $58,959,000 | +424.2% | 1,238,624 | +398.0% | 0.28% | +401.8% |
| Q2 2016 | $11,248,000 | -53.5% | 248,741 | -57.8% | 0.06% | -53.3% |
| Q1 2016 | $24,203,000 | +2040.0% | 589,168 | +1888.1% | 0.12% | +1900.0% |
| Q4 2015 | $1,131,000 | +4.0% | 29,635 | -10.5% | 0.01% | 0.0% |
| Q3 2015 | $1,088,000 | -63.5% | 33,122 | -22.3% | 0.01% | -60.0% |
| Q2 2015 | $2,982,000 | +5.1% | 42,648 | +3.0% | 0.02% | +7.1% |
| Q1 2015 | $2,836,000 | -11.4% | 41,406 | -5.2% | 0.01% | -12.5% |
| Q4 2014 | $3,201,000 | +0.5% | 43,681 | -1.5% | 0.02% | +6.7% |
| Q3 2014 | $3,184,000 | +16.0% | 44,359 | +16.9% | 0.02% | +15.4% |
| Q2 2014 | $2,744,000 | -29.1% | 37,949 | -27.8% | 0.01% | -27.8% |
| Q1 2014 | $3,869,000 | -5.3% | 52,585 | -10.5% | 0.02% | -5.3% |
| Q4 2013 | $4,087,000 | -18.2% | 58,762 | -22.8% | 0.02% | -24.0% |
| Q3 2013 | $4,998,000 | -21.0% | 76,090 | -16.7% | 0.02% | -21.9% |
| Q2 2013 | $6,330,000 | – | 91,382 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |